Riskpilot← Back to searchSign inGet full accessDr Özalp AB
ABActiveOrg 5569574048Bygatan 16 Lgh 1001General medical practice activities · NACE 8621Est. 20140 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
98.6%
Financial strength
Net profit 2024
SEK 1K
0% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +0% |
| Net profit | SEK 1K | +0% |
| Total assets | SEK 1,2M | +0% |
| Equity | SEK 1,1M | +0% |
| Employees | 0 | — |
Legal name
Dr Özalp AB
Org number
5569574048
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 januari 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för företagets verksamhet är att erbjuda läkartjänster som distriktsläkare, d v s läkartjänster till t ex vårdcentraler
Address
Bygatan 16 Lgh 1001
Email
drmoezalp1@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | −2 | −5 | −2 | −2 |
| Depreciation & amort. | — | −2 | −0 | −0 | −0 |
| EBIT | 0 | −4 | −5 | −2 | −2 |
| Net financials | — | — | — | 3 | 3 |
| Profit before tax | 0 | −4 | −5 | 1 | 1 |
| Tax | — | −0 | −0 | −0 | −0 |
| Net profit | — | −4 | −5 | 1 | 1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 1 155 | 1 150 | 1 151 | 1 152 |
| Equity | — | 1 139 | 1 133 | 1 135 | 1 136 |
| Long-term debt | — | 0 | 0 | 0 | 0 |
| Short-term debt | — | 16 | 16 | 16 | 16 |
| Total debt | — | 16 | 16 | 16 | 16 |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20202024
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20202024
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20202024
Net profit margin
100000.0%
This company
8.1%
Market median
+1234468% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Özalp AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Durdana Zeyniyeva-Özalp | Deputy Board Member | 0 companies |
| Fazel Mahmood Fazly | Deputy Board Member | 0 companies |
| Muzaffer Özalp | Board of Directors | 0 companies |